Used as a potent inhibitor in cancer research, particularly targeting tyrosine kinases involved in tumor growth and proliferation. It shows activity against pathways associated with solid tumors, including those in breast, lung, and prostate cancers. The compound is utilized in preclinical studies to evaluate its efficacy in blocking signal transduction pathways that drive cancer progression. Its structure allows for strong binding to ATP sites in kinase enzymes, making it a valuable tool in developing targeted therapies. Also employed in structure-activity relationship (SAR) studies to design more effective and selective anticancer agents.